
Nature's Sunshine Products is upgraded to 'strong buy' despite a 47.9% stock decline and reduced 2026 guidance. NATR remains fundamentally healthy, with robust cash reserves ($82.5M), zero debt, and e

Nature's Sunshine Products NASDAQ: NATR outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, d
Nature's Sunshine Products, Inc. (NATR) Q2 2026 Earnings Call Transcript
Nature's Sunshine Products NASDAQ: NATR reported second-quarter net sales of $117 million, its strongest second quarter in company history, as digital growth in North America and continued momentum ac
LEHI, Utah, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, today ann